Lihua Cao

Dr. Lihua Cao


Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 June 2018 in Orphanet Journal of Rare Diseases
Verified
Journal Article
Open access
PDF file
JLJingyan Li
Jingyan Li
YLYunji Leng
Yunji Leng
SHShirui Han
Shirui Han
LYLulu Yan
Lulu Yan
CLChaoxia Lu
Chaoxia Lu
LCLihua Cao
Lihua Cao
Pediatric cataract is a clinically and genetically heterogeneous disease which is a significant cause of lifelong visual impairment and treatable blindness. Our study aims to investigate the genotype spectrum in a group of Chinese patients with pediatric cataract. We enrolled 39 families with pediatric cataract from October 2015 to April 2016. DNA samples of the probands were analyzed by target next-generation sequencing. Variants were validated using Sanger sequencing in the probands and available family members. In our cohort of 39 cases with different types of pediatric cataract, 23 cases were found to harbor putative pathogenic variants in 15 genes: CRYAA, CRYBA1, CRYBA4, CRYBB1, CRYGC, CRYGD, MIP, GCNT2, IARS2, NHS, BCOR, BFSP2, FYCO1, MAF, and PAX6. The mutation detection rates in the familial and sporadic cases were 75 and 47.8%, respectively. Of the 23 causative variants, over half were novel. This is a rare report of systematic mutation screening analysis of pediatric cataract in a comparably large cohort of Chinese patients. Our observations enrich the mutation spectrum of pediatric cataract. Next-generation sequencing provides significant diagnostic information for pediatric cataract cases, especially when considering sporadic and subtle syndromal cases.

3 May 2018 in The Journal of Dermatology
Verified
Journal Article
Closed access
PDF file
YLYunji Leng
Yunji Leng
LYLulu Yan
Lulu Yan
HFHongquan Feng
Hongquan Feng
CCChen Chen
Chen Chen
SWShusen Wang
Shusen Wang
LCLihua Cao
Lihua Cao

1 October 2018 in Gene
Verified
Journal Article
Closed access
TZTianxiao Zhang
Tianxiao Zhang
LYLulu Yan
Lulu Yan
YLYunji Leng
Yunji Leng
CCChen Chen
Chen Chen
LMLiwei Ma
Liwei Ma
LCLihua Cao
Lihua Cao

28 March 2022 in Neurological Sciences
Verified
Journal Article
Closed access
PDF file
YHYu Hu
Yu Hu
ZTZhen Tian
Zhen Tian
BZBin Zhao
Bin Zhao
CDChuansheng Dong
Chuansheng Dong
LCLihua Cao
Lihua Cao

14 June 2023 in Human Heredity
Verified
Journal Article
Open access
PDF file
WZWenjing Zhang
Wenjing Zhang
XNXinmiao Nie
Xinmiao Nie
LSLei Shi
Lei Shi
FSFengmin Shao
Fengmin Shao
LCLihua Cao
Lihua Cao
Background: Porokeratosis is a rare chronic progressive hypokeratotic skin disease, possibly related to the mevalonate pathway. Variations in four enzymes, including phosphomevalonate kinase (PMVK) may alter this pathway, ultimately leading to porokeratosis. Objectives: The aim of the study was to identify the causative gene variant of porokeratosis in a Chinese family and investigate its population frequency and pathogenicity. Method: In this study, Sanger sequencing was used to identify the gene variant causative of porokeratosis; its population frequency was investigated by polymerase chain reaction-restriction fragment length polymorphism in 4 patients and three normal individuals as well as in 100 normal unrelated controls; finally, the pathogenicity of the mutation and the associated structural changes were predicted. Results: We identified a novel heterozygous missense variant, c.207G>T (p. Lys69Asn) in the PMVK gene. This variant was found in all patients but not in the normal individuals in this family or in the 100 controls. In silico analysis indicated that the variant was pathogenic; p.Lys69Asn changed the length of the α-helix and the hydrogen bond pattern compared with the wild-type protein. Conclusions: The novel variant c.207G>T (p. Lys69Asn) in the PMVK gene was the causative variant in this porokeratosis family. This finding provides further evidence for the genetic basis of this disease.

5 September 2022 in BMC Pediatrics
Verified
Journal Article
Open access
PDF file
JSJiaqi Shao
Jiaqi Shao
YLYue Liu
Yue Liu
YZyj zhao
yj zhao
WSWeisheng Sun
Weisheng Sun
JZJie Zhan
Jie Zhan
LCLihua Cao
Lihua Cao
Background: Brachydactyly type B is an autosomal dominant disorder that is characterized by hypoplasia of the distal phalanges and nails and can be divided into brachydactyly type B1 (BDB1) and brachydactyly type B2 (BDB2). BDB1 is the most severe form of brachydactyly and is caused by truncating variants in the receptor tyrosine kinase–like orphan receptor 2 (ROR2) gene. Case presentation: Here, we report a five-generation Chinese family with brachydactyly with or without syndactyly. The proband and her mother underwent digital separation in syndactyly, and the genetic analyses of the proband and her parents were provided. The novel heterozygous frameshift variant c.1320dupG, p.(Arg441Alafs*18) in the ROR2 gene was identified in the affected individuals by whole-exome sequencing and Sanger sequencing. The c.1320dupG variant in ROR2 is predicted to produce a truncated protein that lacks tyrosine kinase and serine/threonine- and proline-rich structures and remarkably alters the tertiary structures of the mutant ROR2 protein. Conclusion: The c.1320dupG, p.(Arg441Alafs*18) variant in the ROR2 gene has not been reported in any databases thus far and therefore is novel. Our study extends the gene variant spectrum of brachydactyly and may provide information for the genetic counselling of family members.